- Home
- CXM vs PSNL Comparison
CXM vs PSNL Comparison
Compare CXM & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CXM | PSNL |
|---|---|---|
| Founded | 2009 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | CXM | PSNL |
|---|---|---|
| Price | $6.86 | $14.16 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 5 |
| Target Price | $8.28 | ★ $12.20 |
| AVG Volume (30 Days) | 2.9M | ★ 4.7M |
| Earning Date | 06-03-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 33.58 |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $857,200,000.00 | $69,648,000.00 |
| Revenue This Year | $2.52 | $15.34 |
| Revenue Next Year | $4.94 | $41.46 |
| P/E Ratio | $330.50 | ★ N/A |
| Revenue Growth | ★ 7.64 | N/A |
| 52 Week Low | $4.72 | $4.43 |
| 52 Week High | $8.85 | $16.39 |
Technical Indicators
Market Signals| Indicator | CXM | PSNL |
|---|---|---|
| Relative Strength Index (RSI) | 68.10 | 51.90 |
| Support Level | $4.95 | $6.68 |
| Resistance Level | $7.62 | $16.39 |
| Average True Range (ATR) | 0.27 | 0.75 |
| MACD | 0.07 | -0.08 |
| Stochastic Oscillator | 87.31 | 46.75 |
Price Performance
Historical ComparisonAbout CXM Sprinklr Inc.
Sprinklr Inc is engaged in enabling customer-facing teams, from Customer Service to Marketing, to collaborate across internal silos, communicate across digital channels, and leverage AI to deliver customer experiences at scale, all on one unified AI-based platform. It focuses on empowering companies to deliver next-generation, unified engagement journeys that reimagine the customer's experience. Its products include Sprinklr Service, Sprinklr Social, Sprinklr Insights, and Sprinklr Marketing. The company operates in the Americas, EMEA, and other countries. It derives maximum revenue from the Americas.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.